0615-8611Level 3
Ranolazine (Ranolazine)
**Product type:** Human Prescription Drug
**Active ingredient:** RANOLAZINE
**Strength:** 500 mg/1
**Dosage form:** Tablet, Extended Release
**Route:** Oral
**Labeler:** NCS HealthCare of KY, LLC dba Vangard Labs
**Marketing category:** ANDA (ANDA210188)
**Pharmacologic class:** Anti-anginal [EPC], Cytochrome P450 2D6 Inhibitors [MoA], Cytochrome P450 3A Inhibitors [MoA], Organic Cation Transporter 2 Inhibitors [MoA], P-Glycoprotein Inhibitors [MoA]
GET
/api/v1/systems/ndc_fda/nodes/0615-8611Hierarchy Explorer
Loading...
Cross-system equivalences0
No cross-system equivalences mapped for this node.